GPT and COVID-19: Increasing evidences support that patients with COVID-19 could develop liver injury mainly manifested as abnormal ALT or AST levels accompanied by slightly elevated bilirubin levels (Wang et al., 2020; Chen et al., 2020a; Xu et al., 2020a).